Xylazine Activates Adenosine Monophosphate-Activated Protein Kinase Pathway in the Central Nervous System of Rats.
Xylazine is a potent analgesic extensively used in veterinary and animal experimentation. Evidence exists that the analgesic effect can be inhibited using adenosine 5'-monophosphate activated protein kinase (AMPK) inhibitors. Considering this idea, the aim of this study was to investigate wheth...
Main Authors: | Xing-Xing Shi, Bai-Shuang Yin, Peng Yang, Hao Chen, Xin Li, Li-Xue Su, Hong-Gang Fan, Hong-Bin Wang |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2016-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC4822969?pdf=render |
Similar Items
-
Adenosine monophosphate–activated protein kinase in diabetic nephropathy
by: Yaeni Kim, et al.
Published: (2016-06-01) -
Electroacupuncture preconditioning attenuates ischemic brain injury by activation of the adenosine monophosphate-activated protein kinase signaling pathway
by: Qiang-qiang Ran, et al.
Published: (2015-01-01) -
Down-regulation of adenosine monophosphate–activated protein kinase activity: A driver of cancer
by: Xiaoling He, et al.
Published: (2017-04-01) -
Diabetic conditions modulate the adenosine monophosphate-activated protein kinase of podocytes
by: Tae-Sun Ha, et al.
Published: (2014-03-01) -
Adenosine monophosphate-activated protein kinase-based classification of diabetes pharmacotherapy
by: D Dutta, et al.
Published: (2017-01-01)